{"disease":{"id":"hemorrhagic-disease-of-the-newborn-due-to-vitamin-k-deficiency","name":"Hemorrhagic disease of the newborn due to vitamin K deficiency","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"menatetrenone","indication_name":"Hemorrhagic disease of the newborn due to vitamin K deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin Mk 4","generic_name":"MENATETRENONE","company_name":"","drug_phase":"discontinued","molecular_target":"Alpha-synuclein","drug_class":"menatetrenone","quality_score":null,"revenue":null,"mechanism":"Menatetrenone works by acting as a vitamin K analog to promote blood clotting."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}